Exchange: NASDAQ·Updated 04:10 PM EST

LNSR News

News
all
press releases
LENSAR (NASDAQ:LNSR) Director Sells $54,476.17 in Stock
LENSAR, Inc. (NASDAQ:LNSR - Get Free Report) Director Elizabeth O'farrell sold 10,961 shares of LENSAR stock in a transaction dated Wednesday, November 18th. The shares were sold at an average price of $4.97, for a total transaction of $54,476.17. Following the completion of the transaction, the...
MarketBeat
LENSAR (NASDAQ:LNSR) Director Sells $54,476.17 in Stock
LENSAR, Inc. (NASDAQ:LNSR - Get Free Report) Director Elizabeth O'farrell sold 10,961 shares of LENSAR stock in a transaction dated Wednesday, November 18th. The shares were sold at an average price of $4.97, for a total transaction of $54,476.17. Following the completion of the transaction, the...
MarketBeat
More News
LENSAR, Inc. (NASDAQ:LNSR - Get Free Report) Director Elizabeth O'farrell sold 22,214 shares of the stock in a transaction on Tuesday, November 17th. The stock was sold at an average price of $5.20, for a total transaction of $115,512.80. Following the sale, the director owned 67,368 shares of the...
MarketBeat
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
(RTTNews) - LENSAR, Inc. (LNSR) reported Loss for its third quarter of -$4.72 million...
Nasdaq News: Markets
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million. LENSAR (NASDAQ:LNSR) shares increased byread more...
Benzinga
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
LENSAR, Inc. (NASDAQ:LNSR - Get Free Report) was the target of a large growth in short interest in March. As of March 31st, there was short interest totaling 1,016,420 shares, a growth of 42.2% from the March 15th total of 714,594 shares. Approximately 24.7% of the company's stock are short sold...
MarketBeat
Lake Street Capital raised LENSAR from a "hold" rating to a "buy" rating and set a $10.00 price objective for the company in a research note on Wednesday...
MarketBeat
LENSAR (NASDAQ:LNSR) executives used the company's fourth-quarter and full-year 2025 earnings call to outline how the cataract-laser maker plans to reaccelerate growth as a standalone company...
MarketBeat

Advertisement|Remove ads.